With a view towards heightened clinical application, future studies should consider impact of varying diabetes duration on NOX4 angiogenic signalling using peripheral blood ECFCs from adult donors at different disease stages, including consideration of likely influence of diabetes medication, whilst noting that these cells are technically challenging and difficult to both isolate and culture [15]. The gene discussed is NOX4; the disease is diabetes mellitus.